Long-Term Survival, Burden of Disease, and Patient-Centered Outcomes in Maximally Treated Intracerebral Hemorrhage (2025) Mrochen A, Sprügel M, Sekita A, Balk S, Haupenthal D, Gerner S, Lücking H, et al. Journal article HPDL Variant Type Correlates With Clinical Disease Onset and Severity (2025) Lee EH, Kim-Mcmanus O, Yang JH, Haas R, Zaki MS, Abdel-Salam GM, Nakamura Y, et al. Journal article Late-onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB/D (2024) Mächtel R, Dobert J, Hehr U, Weiß A, Kettwig M, Laugwitz L, Groeschel S, et al. Journal article Mobile digital gait analysis objectively measures progression in hereditary spastic paraplegia (2023) Loris E, Ollenschläger M, Greinwalder T, Eskofier B, Winkler J, Gaßner H, Regensburger M Journal article Carbamazepine efficacy in a severe electro-clinical presentation of SLC13A5-epilepsy (2022) Santalucia R, Vilain C, Soblet J, De Laet C, Vuckovic A, König J, Aeby A Journal article Hematoma enlargement characteristics in deep versus lobar intracerebral hemorrhage (2020) Sembill J, Kuramatsu J, Gerner S, Sprügel M, Röder S, Madžar D, Hagen M, et al. Journal article Impact of Fc gamma R variants on the response to alemtuzumab in multiple sclerosis (2019) Keller CW, Ruck T, Mchugh D, Pfeuffer S, Gross CC, Korsukewitz C, Melzer N, et al. Journal article Encephalopathies with KCNC1 variants: genotype-phenotype-functional correlations (2019) Cameron JM, Maljevic S, Nair U, Aung YH, Cogne B, Bezieau S, Blair E, et al. Journal article CSF nonphosphorylated Tau as a biomarker for the discrimination of AD from CJD (2018) Ermann N, Lewczuk P, Schmitz M, Lange P, Knipper T, Goebel S, Kornhuber J, et al. Journal article The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis (2018) Hammer A, Waschbisch A, Kuhbandner K, Bayas A, Lee DH, Duscha A, Haghikia A, et al. Journal article